Learn More
Medchemexpress LLC SPR719 (VXc-486) | 1384984-18-2 | 99.4% | 100 MG

Supplier: Medchemexpress LLC HY12930100MG
SPR719 (VXc-486) is an orally active gyrase B inhibitor with bactericidal activity. It shows promise for research into lung disease caused by non-tuberculous mycobacteria (NTM). It potently inhibits multiple agent-sensitive and drug-resistant isolates of *Mycobacterium tuberculosis*.
- Potently inhibits *Mycobacterium tuberculosis*
- Active against agent-sensitive and drug-resistant isolates
- Promising for research into lung disease caused by non-tuberculous mycobacteria
- Inhibits *M. tuberculosis* replication in macrophages
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.